Spyre Therapeutics (SYRE) Operating Margin (2015 - 2026)
Spyre Therapeutics (SYRE) operating margin from Jun 30, 2015 to Mar 31, 2026. The current Spyre Therapeutics (SYRE) operating margin is -652.00%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Spyre Therapeutics (SYRE)
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -27224.72% | N/A |
| 2023 | -27224.72% | +648.21% |
| 2022 | -3638.63% | N/A |
| 2022 | -3638.63% | +938.66% |
| 2021 | -350.32% | N/A |
| 2021 | -350.32% | -70.02% |
| 2018 | -1168.64% | +187.63% |
| 2018 | -406.30% | -25.54% |
| 2018 | -545.70% | +2.71% |
| 2017 | -531.29% | -16.32% |
| 2017 | -634.92% | +39.83% |
| 2017 | -454.05% | -29.70% |
| 2017 | -645.92% | +36.49% |
| 2016 | -473.22% | -99.16% |
| 2015 | -56550.00% | N/A |
Comparison Spyre Therapeutics (SYRE) operating margin with competitors
Spyre Therapeutics (SYRE) operating margin is -652.00%.